Address

Sofinnova Ventures Inc
2800 Sand Hill Road
Suite 150
Menlo Park, CA 94025
United States

Open map


Recent investment activity

KANDO id: 2247

Corporate information

Founders
Registration country

Funds managed

Fund Type Vintage Currency Committed capital IRR
Sofinnova Industrial Biotech Venture 2017 EUR 106,000,000
Sofinnova Venture Partners X LP Venture 2016 USD 650,000,000
Sofinnova Venture Partners IX LP Venture 2014 USD 500,000,000
Sofinnova Venture Partners VIII LP Venture 2011 USD 440,000,000
Sofinnova Venture Partners VII LP Venture 2006 USD 375,000,000 17.11 %
Sofinnova Venture Partners VI Venture 2003 USD 220,000,000 -6.03 %
Sofinnova Venture Partners V Venture 2000 USD 210,000,000

Funding rounds


Investment activity status
Active investor

Selected investments

Displaying 1 - 48 of 48
Profile Country Date Funding
Ascenta Therapeutics Inc A privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. N/A
Auris Medical Series C
BeamReach Networks Inc N/A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series B
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series C
Cebix Inc N/A
Cebix Inc Series B
Cellective Therapeutics Inc N/A
CoAxia Inc A medical device company that researches therapy and treatment solutions for cerebral ischemia Series D
Contextream Inc ConteXtream is a privately held software company. Series A
Cortina Systems Inc N/A
CoTherix Inc N/A
DiObex Inc Biotechnology company that develops novel products for the treatment of metabolic disorders. N/A
Durata Therapeutics Inc Durata Therapeutics is a clinical development stage biopharmaceutical company. N/A
Envivio Inc Developer of MPEG-4 solutions for broadcasters, enterprises, and service providers. N/A
Flexion Therapeutics Inc Discovers and develops innovative therapeutics for musculoskeletal disorders N/A
Histogenics Corp Histogenics Corporation expertise and focus is on repairing articular cartilage damage. Series A
Hyperion Therapeutics Inc Hyperion Therapeutics is a privately held specialty pharmaceutical company focused on the development of therapies that address critical unmet needs i N/A
INSIDE Secure SA N/A
InterMune Inc N/A
KaloBios Pharmaceuticals Inc Develops first- or best-in-class antibody therapeutics in the fields of autoimmunity N/A
Kosan Biosciences Inc N/A
Laszlo Systems Inc N/A
Marinus Pharmaceuticals Inc Development of therapeutics for treatment of CNS disorders and pain Series A
Marinus Pharmaceuticals Inc Development of therapeutics for treatment of CNS disorders and pain Series B
Mondo Media Inc Animated mini-show media company. N/A
Neurotech Pharmaceuticals Inc (Neurotech Inc) Cell-based drugs for diseases of the eye. N/A
Ocera Therapeutics Inc Development of drugs to treat gastrointestinal diseases N/A
Orexigen Therapeutics Inc N/A
Prestwick Pharmaceuticals Inc A specialty pharmaceutical company engaged in the development and marketing of drugs for diseases of the CNS. N/A
SARcode Bioscience Inc Series B
Sequoia Pharmaceuticals Inc Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. N/A
Solsoft Inc Network security policy management solutions company. N/A
Synacom Technology Inc N/A
Threshold Pharmaceuticals Inc N/A
Trius Therapeutics Inc N/A
Tumbleweed Communications Corp N/A
Vicept Therapeutics Inc Series A
WebDialogs Inc Web conferencing and communications services company. N/A
Aerie Pharmaceuticals Inc Series B
Alvine Pharmaceuticals Inc An innovative biopharmaceutical company developing biologics to target autoimmune/ inflammatory diseases. N/A
Anthera Pharmaceuticals Inc N/A
Calient Technologies Inc Optical switches for enhanced data center performance. Venture
Cerenis Therapeutics SA Series C
InteKrin Therapeutics Inc Biopharmaceutical company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders.. Series C
Intellikine Series B
Nextwave Pharmaceuticals Inc Specialty pharmaceutical company, focused on pediatric neurology. N/A

Former team members

Employee Company Position
[node:title] photo Eric Buatois Benhamou Global Ventures LLC

Selected Products / Customers

Financials